Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-08

AUTHORS

T Ahmadi, J McQuade, D Porter, N Frey, A W Loren, S C Goldstein, J Svoboda, E Stadtmauer, S J Schuster, S D Nasta

ABSTRACT

We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or auto-SCT. The primary study end point was PFS; secondary end point was overall survival.Median follow up for all patients was 3.3 years. Median age was 54 years, and 95% (n=42) were stage III or IV at diagnosis. In all, 17 patients underwent consolidative auto-SCT and 12 patients received R maintenance. The overall response rate was 95%, with 91% achieving complete response (CR). Median PFS for all patients was 3.5 years. Median PFS was 2.3 years for patients treated with R-HyperCVAD alone vs 3.9 years (P=0.02) with R-HyperCVAD+ R maintenance and 4.5 years (P=0.01) with R-HyperCVAD+ auto-SCT. For patients who did not achieve CR at interim staging, PFS for R-HyperCVAD alone was 1.4 years vs not reached for R-HyperCVAD+ consolidation (either R maintenance or auto-SCT) (P=0.02). PFS for patients with CR at interim staging was 3.3 years vs not reached (P=0.04) after consolidation. Our data suggest potential improvement in PFS when R-HyperCVAD is consolidated with either R maintenance or auto-SCT. This benefit appears particularly significant in those patients who do not achieve CR at interim restaging. More... »

PAGES

1082

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2011.218

DOI

http://dx.doi.org/10.1038/bmt.2011.218

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006686198

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22080969


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Murine-Derived", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Mantle-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahmadi", 
        "givenName": "T", 
        "id": "sg:person.01240050411.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240050411.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Department of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McQuade", 
        "givenName": "J", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Porter", 
        "givenName": "D", 
        "id": "sg:person.0707416147.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frey", 
        "givenName": "N", 
        "id": "sg:person.01342471137.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loren", 
        "givenName": "A W", 
        "id": "sg:person.0613365041.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldstein", 
        "givenName": "S C", 
        "id": "sg:person.016115210252.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Svoboda", 
        "givenName": "J", 
        "id": "sg:person.0722677225.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stadtmauer", 
        "givenName": "E", 
        "id": "sg:person.01044042041.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schuster", 
        "givenName": "S J", 
        "id": "sg:person.014567760612.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014567760612.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nasta", 
        "givenName": "S D", 
        "id": "sg:person.01001105007.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001105007.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1182/blood-2006-05-021113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001773472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2010.08228.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004342869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2010.08228.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004342869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.2003.04140.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011769252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.08.133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012126812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-03-147025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014062347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018683246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024531918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-08-2476", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025513720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.17.1561", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036111565"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.1825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036898047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-10-3883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040043539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045509899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.11838", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052550962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.16.8435", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053491476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-04-016725", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053696274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.5.1288", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202851"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.08.674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076949215", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.annonc.a059155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082434789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.8.2780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083306001"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-08", 
    "datePublishedReg": "2012-08-01", 
    "description": "We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or auto-SCT. The primary study end point was PFS; secondary end point was overall survival.Median follow up for all patients was 3.3 years. Median age was 54 years, and 95% (n=42) were stage III or IV at diagnosis. In all, 17 patients underwent consolidative auto-SCT and 12 patients received R maintenance. The overall response rate was 95%, with 91% achieving complete response (CR). Median PFS for all patients was 3.5 years. Median PFS was 2.3 years for patients treated with R-HyperCVAD alone vs 3.9 years (P=0.02) with R-HyperCVAD+ R maintenance and 4.5 years (P=0.01) with R-HyperCVAD+ auto-SCT. For patients who did not achieve CR at interim staging, PFS for R-HyperCVAD alone was 1.4 years vs not reached for R-HyperCVAD+ consolidation (either R maintenance or auto-SCT) (P=0.02). PFS for patients with CR at interim staging was 3.3 years vs not reached (P=0.04) after consolidation. Our data suggest potential improvement in PFS when R-HyperCVAD is consolidated with either R maintenance or auto-SCT. This benefit appears particularly significant in those patients who do not achieve CR at interim restaging.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bmt.2011.218", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "name": "Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance", 
    "pagination": "1082", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1fd9589446f549e31ea3bcb31a09434b91c22145694b8b11a57ce794e2a64b05"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22080969"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2011.218"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006686198"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2011.218", 
      "https://app.dimensions.ai/details/publication/pub.1006686198"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000435.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bmt2011218"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      65 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2011.218 schema:about N0908e9d96c9f4baf99dc5b00f03ff7bd
2 N57289a9f33e64f4da9385b6919a0068f
3 N5dc9a06ffe6844d69b09949bc489cd7c
4 N64211398e7b34f9d88b392b6f43d88eb
5 N68db9532cdb747c7ae9efa6debc0fb35
6 N7517a5a97097422486e89b9843abe4df
7 N7cc542b1c65949e3ac287ee2bf582bbd
8 N919e2233c16b4b9dab3ce704ab9149d1
9 Na339978ac45444558c6332581f066496
10 Naa285495f60e4b5486a62e94a18e42a9
11 Naacdf2c5f4174ff093335e848e47e703
12 Nb2be9e2b629143299e15dde2e4707027
13 Nb4052aa62c5f49b8b98049a63194b5a0
14 Nc44ebaecc1b840b1b41e30f25742e98e
15 Ne28b17522adc48d780baa8d1adf60b21
16 Nef683fd175ea491e843e8911239d2dc3
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author N69b44f7315dd4b55a1a28788b3841979
20 schema:citation https://app.dimensions.ai/details/publication/pub.1076949215
21 https://doi.org/10.1002/cncr.11838
22 https://doi.org/10.1046/j.1365-2141.2003.04140.x
23 https://doi.org/10.1093/annonc/mdl127
24 https://doi.org/10.1093/oxfordjournals.annonc.a059155
25 https://doi.org/10.1111/j.1365-2141.2010.08228.x
26 https://doi.org/10.1182/blood-2002-08-2476
27 https://doi.org/10.1182/blood-2004-10-3883
28 https://doi.org/10.1182/blood-2006-04-016725
29 https://doi.org/10.1182/blood-2006-05-021113
30 https://doi.org/10.1182/blood-2008-03-147025
31 https://doi.org/10.1200/jco.1998.16.8.2780
32 https://doi.org/10.1200/jco.20.5.1288
33 https://doi.org/10.1200/jco.2002.08.674
34 https://doi.org/10.1200/jco.2005.01.1825
35 https://doi.org/10.1200/jco.2005.04.164
36 https://doi.org/10.1200/jco.2005.08.133
37 https://doi.org/10.1200/jco.2006.09.2403
38 https://doi.org/10.1200/jco.2008.16.8435
39 https://doi.org/10.1200/jco.2008.17.1561
40 schema:datePublished 2012-08
41 schema:datePublishedReg 2012-08-01
42 schema:description We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or auto-SCT. The primary study end point was PFS; secondary end point was overall survival.Median follow up for all patients was 3.3 years. Median age was 54 years, and 95% (n=42) were stage III or IV at diagnosis. In all, 17 patients underwent consolidative auto-SCT and 12 patients received R maintenance. The overall response rate was 95%, with 91% achieving complete response (CR). Median PFS for all patients was 3.5 years. Median PFS was 2.3 years for patients treated with R-HyperCVAD alone vs 3.9 years (P=0.02) with R-HyperCVAD+ R maintenance and 4.5 years (P=0.01) with R-HyperCVAD+ auto-SCT. For patients who did not achieve CR at interim staging, PFS for R-HyperCVAD alone was 1.4 years vs not reached for R-HyperCVAD+ consolidation (either R maintenance or auto-SCT) (P=0.02). PFS for patients with CR at interim staging was 3.3 years vs not reached (P=0.04) after consolidation. Our data suggest potential improvement in PFS when R-HyperCVAD is consolidated with either R maintenance or auto-SCT. This benefit appears particularly significant in those patients who do not achieve CR at interim restaging.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree true
46 schema:isPartOf N5abdf41930d440e39cc7ea52d36a7b75
47 Nb1e96fbbff9d4f919077f12636619733
48 sg:journal.1096890
49 schema:name Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance
50 schema:pagination 1082
51 schema:productId N0c141c472e5e4c418ebf957eba684050
52 N2ba281b6c5d6470c837a42f7402f5c3e
53 N9d11a4402bb14b20812dae40a42cf23d
54 Nd789f4103d194f54a85fa578307aebdf
55 Nec9c9f83ffcd4e6cb1c3aea9c635676a
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006686198
57 https://doi.org/10.1038/bmt.2011.218
58 schema:sdDatePublished 2019-04-10T18:09
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher Naf597b77e7d14d1eaafea19de794136f
61 schema:url https://www.nature.com/articles/bmt2011218
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N0908e9d96c9f4baf99dc5b00f03ff7bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Follow-Up Studies
67 rdf:type schema:DefinedTerm
68 N0c141c472e5e4c418ebf957eba684050 schema:name nlm_unique_id
69 schema:value 8702459
70 rdf:type schema:PropertyValue
71 N177957f3ff554cf5bfbd8e576be0f5cc rdf:first sg:person.0707416147.15
72 rdf:rest N80ae849938314fefb49bf365499d5252
73 N178e78ba168046ee9fa77c47a2800722 rdf:first sg:person.014567760612.40
74 rdf:rest Ne3b8510b8a5244c8a2ba605af825a1a7
75 N29686f59ce9f40e29f172489cc1159cd rdf:first sg:person.0722677225.98
76 rdf:rest Ncd0bb95914a34abf86237d67ae5844ed
77 N2ba281b6c5d6470c837a42f7402f5c3e schema:name doi
78 schema:value 10.1038/bmt.2011.218
79 rdf:type schema:PropertyValue
80 N57289a9f33e64f4da9385b6919a0068f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Time Factors
82 rdf:type schema:DefinedTerm
83 N5abdf41930d440e39cc7ea52d36a7b75 schema:volumeNumber 47
84 rdf:type schema:PublicationVolume
85 N5d96f498f5c74da3820448e73ca685c6 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
86 schema:familyName McQuade
87 schema:givenName J
88 rdf:type schema:Person
89 N5dc9a06ffe6844d69b09949bc489cd7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Stem Cell Transplantation
91 rdf:type schema:DefinedTerm
92 N5ff119bb61af442eac45793fdec5566c rdf:first sg:person.016115210252.03
93 rdf:rest N29686f59ce9f40e29f172489cc1159cd
94 N64211398e7b34f9d88b392b6f43d88eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Antineoplastic Combined Chemotherapy Protocols
96 rdf:type schema:DefinedTerm
97 N68db9532cdb747c7ae9efa6debc0fb35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Humans
99 rdf:type schema:DefinedTerm
100 N69b44f7315dd4b55a1a28788b3841979 rdf:first sg:person.01240050411.42
101 rdf:rest Ne67edf0d199c487e813629f2475f2b7a
102 N7517a5a97097422486e89b9843abe4df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Middle Aged
104 rdf:type schema:DefinedTerm
105 N7cc542b1c65949e3ac287ee2bf582bbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Male
107 rdf:type schema:DefinedTerm
108 N80ae849938314fefb49bf365499d5252 rdf:first sg:person.01342471137.57
109 rdf:rest Nd2e281eb89164dd289ede97b789b8374
110 N919e2233c16b4b9dab3ce704ab9149d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Female
112 rdf:type schema:DefinedTerm
113 N9d11a4402bb14b20812dae40a42cf23d schema:name readcube_id
114 schema:value 1fd9589446f549e31ea3bcb31a09434b91c22145694b8b11a57ce794e2a64b05
115 rdf:type schema:PropertyValue
116 Na339978ac45444558c6332581f066496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Transplantation, Autologous
118 rdf:type schema:DefinedTerm
119 Naa285495f60e4b5486a62e94a18e42a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Disease-Free Survival
121 rdf:type schema:DefinedTerm
122 Naacdf2c5f4174ff093335e848e47e703 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Antibodies, Monoclonal, Murine-Derived
124 rdf:type schema:DefinedTerm
125 Naf597b77e7d14d1eaafea19de794136f schema:name Springer Nature - SN SciGraph project
126 rdf:type schema:Organization
127 Nb1e96fbbff9d4f919077f12636619733 schema:issueNumber 8
128 rdf:type schema:PublicationIssue
129 Nb2be9e2b629143299e15dde2e4707027 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Survival Rate
131 rdf:type schema:DefinedTerm
132 Nb4052aa62c5f49b8b98049a63194b5a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Lymphoma, Mantle-Cell
134 rdf:type schema:DefinedTerm
135 Nc44ebaecc1b840b1b41e30f25742e98e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Rituximab
137 rdf:type schema:DefinedTerm
138 Ncd0bb95914a34abf86237d67ae5844ed rdf:first sg:person.01044042041.97
139 rdf:rest N178e78ba168046ee9fa77c47a2800722
140 Nd2e281eb89164dd289ede97b789b8374 rdf:first sg:person.0613365041.61
141 rdf:rest N5ff119bb61af442eac45793fdec5566c
142 Nd789f4103d194f54a85fa578307aebdf schema:name dimensions_id
143 schema:value pub.1006686198
144 rdf:type schema:PropertyValue
145 Ne28b17522adc48d780baa8d1adf60b21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Retrospective Studies
147 rdf:type schema:DefinedTerm
148 Ne3b8510b8a5244c8a2ba605af825a1a7 rdf:first sg:person.01001105007.49
149 rdf:rest rdf:nil
150 Ne67edf0d199c487e813629f2475f2b7a rdf:first N5d96f498f5c74da3820448e73ca685c6
151 rdf:rest N177957f3ff554cf5bfbd8e576be0f5cc
152 Nec9c9f83ffcd4e6cb1c3aea9c635676a schema:name pubmed_id
153 schema:value 22080969
154 rdf:type schema:PropertyValue
155 Nef683fd175ea491e843e8911239d2dc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Neoplasm Staging
157 rdf:type schema:DefinedTerm
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
162 schema:name Oncology and Carcinogenesis
163 rdf:type schema:DefinedTerm
164 sg:journal.1096890 schema:issn 0268-3369
165 1476-5365
166 schema:name Bone Marrow Transplantation
167 rdf:type schema:Periodical
168 sg:person.01001105007.49 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
169 schema:familyName Nasta
170 schema:givenName S D
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001105007.49
172 rdf:type schema:Person
173 sg:person.01044042041.97 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
174 schema:familyName Stadtmauer
175 schema:givenName E
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97
177 rdf:type schema:Person
178 sg:person.01240050411.42 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
179 schema:familyName Ahmadi
180 schema:givenName T
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240050411.42
182 rdf:type schema:Person
183 sg:person.01342471137.57 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
184 schema:familyName Frey
185 schema:givenName N
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57
187 rdf:type schema:Person
188 sg:person.014567760612.40 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
189 schema:familyName Schuster
190 schema:givenName S J
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014567760612.40
192 rdf:type schema:Person
193 sg:person.016115210252.03 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
194 schema:familyName Goldstein
195 schema:givenName S C
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03
197 rdf:type schema:Person
198 sg:person.0613365041.61 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
199 schema:familyName Loren
200 schema:givenName A W
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61
202 rdf:type schema:Person
203 sg:person.0707416147.15 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
204 schema:familyName Porter
205 schema:givenName D
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15
207 rdf:type schema:Person
208 sg:person.0722677225.98 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
209 schema:familyName Svoboda
210 schema:givenName J
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98
212 rdf:type schema:Person
213 https://app.dimensions.ai/details/publication/pub.1076949215 schema:CreativeWork
214 https://doi.org/10.1002/cncr.11838 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052550962
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1046/j.1365-2141.2003.04140.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011769252
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/annonc/mdl127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018683246
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/oxfordjournals.annonc.a059155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082434789
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1111/j.1365-2141.2010.08228.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004342869
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1182/blood-2002-08-2476 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025513720
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1182/blood-2004-10-3883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040043539
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1182/blood-2006-04-016725 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053696274
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1182/blood-2006-05-021113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001773472
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1182/blood-2008-03-147025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014062347
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1200/jco.1998.16.8.2780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083306001
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.20.5.1288 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202851
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.2002.08.674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203113
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1200/jco.2005.01.1825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036898047
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2005.04.164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024531918
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1200/jco.2005.08.133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012126812
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1200/jco.2006.09.2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045509899
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.2008.16.8435 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053491476
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.2008.17.1561 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036111565
251 rdf:type schema:CreativeWork
252 https://www.grid.ac/institutes/grid.25879.31 schema:alternateName University of Pennsylvania
253 schema:name Department of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA
254 Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...